CONSTRUCTION OF INTERGENERIC FUSANTS TO ENHANCE IMAZETHAPYR AND CHLORIMURON-ETHYL DEGRADATION

Xiong Minghua,Cheng Yi,Zang Hailian,Cheng Xiaosong,Li Chunyan
2016-01-01
Fresenius environmental bulletin
Abstract:Intergeneric protoplast fusion between Beijerinckia sp. P310-1 and Rhodococcus sp. D310-1 was performed and confirmed. Fusants were constructed to enhance the simultaneous degradation of imazethapyr and chlorimuron-ethyl. Subsequently, the degradation capacity of fusant R3 for imazethapyr and chlorimuron-ethyl was compared with those of the parental strains. Five fusants were obtained from the selective medium with a fusion frequency of approximately 2.03x10(-7). These fusants presented different colony morphologies from the parents and good growth, but they varied in biomass in mineral media containing imazethapyr and chlorimuron-ethyl as the carbon sources. These observations indicate that genetic information from the parental strains was successfully introduced into the fusants. Fusant R3 gained the maximum biomass and produced a unique profile in RAPD analysis, which further confirmed that it was genetically heterogeneous. Fusant R3 degraded 67.3% of imazethapyr and 66.3% of chlorimuron-ethyl, which represented a nearly 1.25-1.41-fold increase compared to the parents. Thus, the fusant had a degradation ability that exceeded those of its parental strains. The fusant may contribute to the development of a consortium for the bioremediation of imazethapyr and chlorimuron-ethyl co-contaminated environments. This study demonstrates that it is possible to improve Rhodococcus sp.D310-1 and Beijerinckia sp. P310-1 by protoplast fusion.
What problem does this paper attempt to address?